Loading...
Images of Mitsuko Takenaga
(0 from 0 )Business Profiles
Researchgate: Mitsuko Takenaga
Kawasaki, Japan
patentbuddy: Mitsuko Takenaga
KEMPHYS LTD., Kanagawa, JP
Books & Literature
Official Gazette of the United States Patent and Trademark Office:...
books.google.de
... MODIFIED INTERFERON Mitsuko Takenaga, 30-1, Sugao 2-chome, Miyamae- ku, Kawasaki-shi, Kanagawa 216; Katsukiyo SakuraiZohshiki 2-chome, ...
Related Documents
Areeya Disratthakit - Academia.edu
independent.academia.edu
Academia.edu is a place to share and follow research.
Possibility of lipid microsphere-encapsulated Y as an injectable ...
www.allergologyinternational.com
... of lipid microsphere-encapsulated Y as an injectable drug and an inhaler for the treatment of bronchoconstriction. Mitsuko Takenaga.
Scientific Publications
Client Request Error
www.sciencedirect.com
Daisuke Asai, Taisei Kanamoto, Mitsuko Takenaga, Hideki Nakashima. Pages Download PDF. Article preview. select article Electrospun formulations of bevacizumab for sustained release in the eye. Research article Full text access
Effect of a soluble pseudo-receptor on verotoxin 2-induced toxicity -...
www.sciencedirect.com
... on verotoxin 2-induced toxicity. Author links open overlay panelMitsuko Takenaga RieIgarashiMegumuHigakiKoichiYukiYutakaMizushimaToshiaki Nakayama.
Publications
JCM | Free Full-Text | Adenosine A2B Receptors: An Optional Target...
www.mdpi.com
Adenosine A 2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea? Teita Asano * and Mitsuko Takenaga Institute of Medical Science, St. Marianna University School of MedicineSugao, Miyamae-ku, Kawasaki , Japan
Prolonging the In Vivo Residence Time of Prostaglandin E1 with...
link.springer.com
Prostaglandins have potent and diverse biologic activities, but their clinical application is severely restricted, mainly due to rapid inactivation in vivo
Reports & Statements
A 2B adenosine receptor inhibition by the dihydropyridine ...www.nature.com › nature › scientific reports › articles
www.nature.com
Teita Asano; & Mitsuko Takenaga. LTT Bio-Pharma Co., Ltd, Shiodome Building 3F, Kaigan, Minato-ku, TokyoJapan.
Miscellaneous
Bioorg. Med. Chem. - X-MOLwww.x-mol.com › paper
en.x-mol.com
... Naoki Yamakawa, Teita Asano, Yuki Kanda, Ayaka Takafuji, Masahiro Kawahara, Mitsuko Takenaga, Yoshifumi Fukunishi, Tohru Mizushima.
Northwest Life Science Specialties
www.nwlifescience.com
Assuming sod is required, the following results were found.
Synthesis of prostaglandin E1 phosphate derivatives and their...
keio.pure.elsevier.com
author = "Miho Takeda and Taishi Maeda and Tsutomu Ishihara and Haruka Sakamoto and Kanae Yuki and Naoko Takasaki and Fumihiro Nishimura and Takeshi Yamashita and Tanaka, {Ken Ichiro} and Mitsuko Takenaga and Rie Igarashi and Megumu Higaki and Naoki Yamakawa and Yoshinari Okamoto and Hisao Ogawa and Masami Otsuka and Yutaka Mizushima and Tohru ...
Neuroprotection, Recovery of Function and Endogenous Neurogenesis in...
read.qxmd.com
... Masanori Ootaki, Minoru Watanabe, Yuko Takeba, Taroh Iiri, Naoki Matsumoto, Mitsuko Takenaga Cytotherapy 2017, 19 (7):
Possibility of lipid microsphere-encapsulated Y as an...
cyberleninka.org
Abstract of research paper on Biological sciences, author of scientific article — Mitsuko Takenaga, Rie Igarashi, Yutaka Mizushima. ABSTRACT Y
Search Citations
www.nwlifescience.com
Assuming superoxide is required, and dismutase is required, the following results were found.
Related search requests for Mitsuko Takenaga
| Akemi Hamaguchi Tsutomu Ishihara Naoki Yamakawa | Yuki Ohta |
People Forename "Mitsuko" (568) Name "Takenaga" (14) |
sorted by relevance / date